# A Translational Study of Bevacizumab in Participants With Metastatic Colorectal Cancer

> **NCT01588990** · PHASE4 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 128 (actual)

## Conditions studied

- Colorectal Neoplasms

## Interventions

- **DRUG:** Oxaliplatin
- **DRUG:** Capecitabine
- **DRUG:** Bevacizumab
- **DRUG:** Leucovorin
- **DRUG:** 5-Fluouracil
- **DRUG:** Irinotecan

## Key facts

- **NCT ID:** NCT01588990
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06-26
- **Primary completion:** 2016-09-15
- **Final completion:** 2016-09-30
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2019-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01588990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01588990, "A Translational Study of Bevacizumab in Participants With Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01588990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*